Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Genuit Group Share Price
  4. Genuit Group Share Regulatory News
  5. Block Listing Application

Pin to quick picksGenuit Group Regulatory News (GEN)

Genuit Group Information

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
256.20    4.20 (1.67%)
Bid:
254.60
Ask:
255.60
Spread: 1.00 (0.393%)
Market Cap: £645.59m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Block Listing Application

30 Mar 2022 15:53

RNS Number : 6481G
Genuit Group PLC
30 March 2022
 

 

 

Genuit Group plc

Block Listing Application

 

Genuit Group plc (the "Company") announces that an application has been made to the London Stock Exchange and FCA for a total of 1,500,000 ordinary shares of £0.001 each in the Company to be admitted to the Official List of the FCA and admitted to trading on the London Stock Exchange.

These shares will be allotted from time to time to satisfy awards granted in accordance with the Genuit Group plc 2014 Long Term Incentive Plan, the Genuit Group plc 2014 Deferred Share Bonus Plan, the Genuit Group plc 2014 Sharesave Scheme and the Genuit Group plc 2020 International Sharesave Plan.

Admission is expected to become effective on 1 April 2022.

The shares will be issued fully paid and will rank pari passu in all respects with the existing issued ordinary shares of the Company.

 

Enquiries:  

 

Emma Versluys

+44 (0) 1138 315315

Company Secretary 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSURSSRUKUOOAR
12345
Date   Source Headline
10th Jun 20244:32 pmRNSHolding(s) in Company
28th May 20242:14 pmRNSResult of AGM
28th May 20247:00 amRNSTrading Update
2nd May 20244:57 pmRNSBlock listing Interim Review
24th Apr 202410:39 amRNSNotice of AGM
10th Apr 20244:24 pmRNSDirector/PDMR Shareholding
10th Apr 20244:17 pmRNSDirector/PDMR Shareholding
9th Apr 20244:28 pmRNSDirector Declaration
2nd Apr 20243:56 pmRNSDirector/PDMR Shareholding
20th Mar 20243:27 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFinal Results
1st Mar 20248:30 amRNSDirector Declaration
19th Feb 20249:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20243:49 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSStrategy Progress Update Notification
15th Nov 20237:00 amRNSTrading Update
9th Nov 202310:08 amRNSDirector Declaration
2nd Nov 202311:59 amRNSDirector/PDMR Shareholding
1st Nov 20234:00 pmRNSBlock listing Interim Review
1st Nov 20237:00 amRNSDirectorate Change
25th Oct 20234:04 pmRNSDirector/PDMR Shareholding
17th Oct 20234:05 pmRNSDirector/PDMR Shareholding
11th Oct 20233:25 pmRNSDirector/PDMR Shareholding
6th Oct 20233:59 pmRNSDirector/PDMR Shareholding
11th Sep 202312:56 pmRNSDirector/PDMR Shareholding
1st Sep 20239:30 amRNSInterim Chief Financial Officer appointment
23rd Aug 20231:34 pmRNSDirector/PDMR Shareholding
18th Aug 202312:14 pmRNSDirector/PDMR Shareholding
16th Aug 202311:42 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSHalf-year Report
27th Jun 202312:01 pmRNSDirector/PDMR Shareholding
12th Jun 20234:11 pmRNSDirectorate Change
6th Jun 20237:00 amRNSDirectorate Change
18th May 202311:40 amRNSResult of AGM
18th May 20237:00 amRNSTrading Update
2nd May 20239:38 amRNSBlock listing Interim Review
25th Apr 20234:19 pmRNSDirector/PDMR Shareholding
25th Apr 20234:16 pmRNSDirector/PDMR Shareholding
18th Apr 202310:49 amRNSNotice of AGM
13th Apr 20233:57 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
31st Mar 20234:27 pmRNSDirector/PDMR Shareholding
17th Mar 202311:28 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
8th Mar 20234:26 pmRNSBoard updates
28th Feb 20235:55 pmRNSHolding(s) in Company
27th Feb 20239:36 amRNSDirectorate Change
31st Jan 202310:22 amRNSDirector Declaration
26th Jan 20236:27 pmRNSHolding(s) in Company
28th Nov 20224:05 pmRNSDirector/PDMR Shareholding
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
APF
APF.L
LSE
0.00%
PAC
Pacific Assets Trust
LSE
0.24%
E2V
E2V.L
LSE
0.00%
DEB
Debenhams
LSE
0.00%
MXF
Medicx Fund
LSE
0.00%
Trending
HE1
Helium One
LSE
6.28%
MAC
Marechale Cap.
LSE
43.84%
NEO
Neo Energy Metals
LSE
-7.30%
IMM
Immupharma
LSE
-5.22%
BSFA
Bio-Sustainable Future Enterprises
LSE
-10.00%